The Riverside Cancer Institute offers the latest technology
When it comes to treating cancer, Riverside knows that access to leading-edge technology plays a key role in giving patients the best outcomes possible.
That’s why we have invested in the addition of a second TrueBeam Linear Accelerator—the latest in cancer treatment technology.
“Adding another TrueBeam allows us to treat even more patients in our community with leading-edge technology,” says Cassandra Lacher, DO, MHA, oncologist and hematologist at the Riverside Cancer Institute.
How it benefits patients
TrueBeam targets tumors with extreme accuracy while minimizing side effects and damage to healthy tissues. This new TrueBeam will also have brachytherapy technology, which is a newer form of cancer treatment that uses internal radiation to treat head and neck cancer, breast cancer, prostate cancer, cervical cancer, and more.
In addition to TrueBeam, patients at the Riverside Cancer Institute have access to surgical oncology, such as da Vinci® robotic surgery to remove tumors with fewer post-operative
complications. The Riverside Cancer Institute also offers patients the latest chemotherapy medications and methods, and newer treatments like immunotherapy, which uses the body’s own defense system to find and destroy cancer cells.
“Treatment options that have become available in the last 10 to 15 years have provided improved outcomes and renewed hope for our cancer patients, and we are grateful to be able to offer them this technology right here in the community,” Dr. Lacher says.
To learn more about technology and treatments available at the Riverside Cancer Institute, visit RiversideHealthcare.org/cancer.